EyesVision Q1 2026: Consolidated revenue up 29.7%, but operating loss and increased debt; no dividends

Q1 2026 consolidated revenue: 46.7 billion KRW (up 29.7% YoY)
Operating loss of 0.17 billion KRW (vs profit in Q1 2025)
Net income of 1.29 billion KRW (includes 2.75 billion KRW bargain purchase gain)
Total liabilities: 101 billion KRW; net debt ratio 27.48% (up from 16.62% at year-end 2025)
Lawsuit of 63.6 billion KRW pending against subsidiary RITCO
No dividend plans on a separate basis
Subsidiary Mercury improved operating profit; RITCO continues loss